Profound Medical Valuation

PRN Stock  CAD 10.21  0.29  2.92%   
At this time, the company appears to be fairly valued. Profound Medical Corp holds a recent Real Value of C$10.16 per share. The prevailing price of the company is C$10.21. Our model determines the value of Profound Medical Corp from analyzing the company fundamentals such as Operating Margin of (1.69) %, shares outstanding of 36.29 M, and Return On Equity of -1.24 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Profound Medical's valuation include:
Price Book
8.2398
Enterprise Value
332.7 M
Enterprise Value Ebitda
(7.93)
Price Sales
25.9181
Enterprise Value Revenue
17.1214
Fairly Valued
Today
10.21
Please note that Profound Medical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Profound Medical Corp is based on 3 months time horizon. Increasing Profound Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Profound Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Profound Stock. However, Profound Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  10.21 Real  10.16 Hype  10.14 Naive  9.63
The intrinsic value of Profound Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Profound Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
10.16
Real Value
13.89
Upside
Estimating the potential upside or downside of Profound Medical Corp helps investors to forecast how Profound stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Profound Medical more accurately as focusing exclusively on Profound Medical's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
-0.49-0.39-0.46
Details
Hype
Prediction
LowEstimatedHigh
6.4110.1413.87
Details
Naive
Forecast
LowNext ValueHigh
5.909.6313.36
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Profound Medical's intrinsic value based on its ongoing forecasts of Profound Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Profound Medical's closest peers.

Profound Medical Cash

34.93 Million

Profound Medical Total Value Analysis

Profound Medical Corp is at this time estimated to have takeover price of 332.75 M with market capitalization of 370.55 M, debt of 5.12 M, and cash on hands of 27.05 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Profound Medical fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
332.75 M
370.55 M
5.12 M
27.05 M

Profound Medical Investor Information

About 34.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.79. Profound Medical Corp last dividend was issued on the 16th of October 2019. The entity had 1:10 split on the 16th of October 2019. Profound Medical Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.

Profound Medical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Profound Medical has an asset utilization ratio of 15.21 percent. This suggests that the Company is making C$0.15 for each dollar of assets. An increasing asset utilization means that Profound Medical Corp is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid
 
Interest Hikes

Profound Medical Profitability Analysis

Taking into consideration Profound Medical's profitability measurements, Profound Medical Corp may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Profound Medical's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2014-03-31
Previous Quarter
-15.7 M
Current Value
-7.9 M
Quarterly Volatility
3.1 M
 
Yuan Drop
 
Covid
 
Interest Hikes
As of the 1st of February 2026, Gross Profit is likely to grow to about 8.5 M, while Pretax Profit Margin is likely to drop (2.46).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.390.59
Way Down
Slightly volatile
For Profound Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Profound Medical Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Profound Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Profound Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Profound Medical over time as well as its relative position and ranking within its peers.

Profound Medical Earnings per Share Projection vs Actual

By analyzing Profound Medical's earnings estimates, investors can diagnose different trends across Profound Medical's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Profound Medical Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
 
Interest Hikes
Profound Medical is projected to generate -0.39 in earnings per share on the 31st of December 2025. Profound Medical earnings estimates show analyst consensus about projected Profound Medical EPS (Earning Per Share). It derives the highest and the lowest estimates based on Profound Medical's historical volatility. Many public companies, such as Profound Medical, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Profound Medical Ownership Allocation

Profound Medical owns a total of 36.29 Million outstanding shares. 30% of Profound Medical Corp outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Profound Medical Profitability Analysis

The company reported the revenue of 10.68 M. Net Loss for the year was (27.82 M) with profit before overhead, payroll, taxes, and interest of 10.36 M.

About Profound Medical Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Profound Medical Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Profound Medical Corp based exclusively on its fundamental and basic technical indicators. By analyzing Profound Medical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Profound Medical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Profound Medical. We calculate exposure to Profound Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Profound Medical's related companies.
Last ReportedProjected for Next Year
Gross Profit8.1 M8.5 M
Pretax Profit Margin(2.34)(2.46)
Operating Profit Margin(2.79)(2.93)
Net Loss(2.34)(2.46)
Gross Profit Margin 0.59  0.39 
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Profound Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.